<p>/PRNewswire/ -- Inari Medical，现在是 Stryker（纽约证券交易所代码：SYK）的一部分，Stryker 是全球医疗技术的领导者，宣布推出其 Artix 血栓切除系统。Artix 专为外周动脉系统的独特需求而设计，是一种结合了吸引和机械血栓切除的解决方案，提供了程序控制和灵活性，旨在为动脉血栓切除设定新的标准。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Artix™血栓切除系统</p>
<p>腿部的动脉血栓是一种危及生命和肢体的紧急情况，需要立即治疗。然而，现有的动脉血栓栓塞治疗可能导致：</p>
<ul>
<li>无效的血栓取出，导致额外的手术（开放手术或截肢 1,2）</li>
<li>大量失血 1</li>
<li>不良事件，如动脉栓塞和血管损伤 2,3</li>
<li>溶栓药物使用率高，可能导致并发症 1,2</li>
</ul>
<p>Artix 系统建立在 Inari 静脉血栓切除设备成功的基础上，是其首次进入动脉领域。Inari 提供了一种全面的工具包方法来进行动脉血栓切除，采用创新的导线系统，使医生能够灵活地吸引和/或机械性提取血栓。</p>
<p>康涅狄格州诺沃克医院血管外科主任 Jonathan Bowman 博士于 2024 年 10 月 19 日进行了首例 Artix 商业案例。Bowman 博士表示：“Artix 血栓切除系统标志着外周动脉血栓栓塞治疗的重大进展。使用 Artix，我终于有了一个有效解决各种血栓的方案，同时能够在整个过程中保持血管通路和控制。我预计 Artix 将在我的许多动脉病例中取代开放手术修复。”</p>
<p>Artix 系统的主要独特特点包括：</p>
<ul>
<li><strong>双重机械血栓切除和吸引工具包</strong>，旨在通过简化的程序在一次会话中去除急性到慢性血栓 4</li>
<li><strong>具备吸引功能的 8 Fr 低剖面、可追踪、抗弯曲的鞘管，长度为 65cm 和 90cm</strong>，通过支持更复杂和远端的干预扩展治疗选项</li>
<li><strong>创新的导线机械元件</strong>，旨在有效收集和提取急性至慢性血栓 4</li>
<li><strong>覆盖的镍钛合金网漏斗</strong>，在手术过程中提供临时流量限制，以最小化动脉血栓迁移的风险 5</li>
</ul>
<p>“确实需要解决慢性血栓并降低血栓迁移的风险。Artix 将提升有效动脉血栓切除的标准，” Inari Medical 首席医疗官 Tom Tu 博士表示。“我们很高兴将 Inari 在血栓切除方面的核心能力带入动脉领域，以改善治疗结果。”</p>
<p><strong>欲了解更多信息，请访问 https://www.inarimedical.com/artix-system</strong></p>
<p><strong>关于 Stryker</strong> Stryker 是全球医疗技术的领导者，与我们的客户一起，我们致力于改善医疗保健。我们提供创新的产品和服务，涵盖外科、神经技术和骨科，帮助改善患者和医疗保健结果。与全球客户一起，我们每年影响超过 1.5 亿名患者。更多信息请访问 www.stryker.com。</p>
<p>2025 年 2 月 19 日，Stryker 收购了 Inari Medical，这是一家致力于治疗和改善患有静脉及其他疾病的患者生活的医疗设备公司。</p>
<p><strong>媒体联系人：</strong></p>
<p>Sherri Oakson</p>
<p>高级传播总监</p>
<p>外科和神经技术</p>
<p>[email protected]</p>
<ol>
<li>De Donato 等。INDIAN 试验。Eur J Vasc Endovasc Surg. 2021; 61: 820-828。</li>
<li>Heller 等。使用 Rotarex 设备进行急性肢体缺血的经皮机械血栓切除。BioMed Research International. 2017。</li>
<li>Olinic 等。急性肢体缺血：诊断和管理的更新。J Clin Med. 2019。</li>
<li>旨在去除急性到慢性动脉血栓。根据与对照组的台式测试。内部数据存档。Narula 等。JACC 2018;72:2153-63</li>
<li>根据与对照组的台式测试。内部数据存档。注意：为了尽量减少动脉血栓迁移的风险，使用一种能够捕捉血栓的设备可能会有帮助，但这尚未在动脉系统中证明有效。</li>
</ol>
<p>Jonathan Bowman 博士是 Inari Medical 的有偿顾问。Jonathan Bowman 博士在此表达的所有观点和意见均为他个人的观点，并不代表 Inari Medical 的观点。</p>
<p><strong>使用指征：</strong> Artix 薄壁鞘管适用于：（1）非手术去除血管中的栓子和血栓。（2）将对比剂和其他液体注入、输注和/或从血管中吸引。（3）作为血管内设备的导管。（4）用于促进将血管内导管插入并引导至选定血管。该漏斗在这些和其他血管造影程序中提供临时血管阻塞。Artix 薄壁鞘管旨在用于外周血管。Artix MT 血栓切除设备适用于（1）非手术去除血管中的栓子和血栓；（2）将对比剂和其他液体注入、输注和/或从血管中吸引。Artix MT 血栓切除设备旨在用于外周血管。Artix AX 吸引导管适用于（1）非手术去除血管中的栓子和血栓；（2）将对比剂和其他液体注入、输注和/或从血管中吸引。Artix AX 吸引导管旨在用于外周血管。FlowSaver 血液回流系统与 Inari Medical 导管和鞘管一起用于自体血液输血。</p>
<p>在使用这些产品之前，请仔细阅读使用说明、适应症、警告、注意事项、可能的不良反应和禁忌症。</p>
<p>来源：Stryker</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz"/></p>

NARI

<p>Inari Medical，现在是 Stryker 的一部分，推出了 Artix 血栓切除系统，旨在治疗外周动脉血栓。该创新系统结合了吸引和机械血栓切除，旨在提高手术控制和灵活性。Artix 系统满足了有效去除急性到慢性血栓的临床需求，可能在许多情况下替代开放手术修复。首例商业使用由 Jonathan Bowman 博士进行，突显了其在改善动脉血栓切除患者结果方面的重要性</p>

<p>, /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral arterial system, Artix is a combined aspiration plus mechanical thrombectomy solution that delivers procedural control and versatility, and is designed to set a new standard for arterial thrombectomy.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Inari Medical，现在是 Stryker（纽约证券交易所代码：SYK）的一部分，Stryker 是全球医疗技术的领导者，宣布推出其 Artix 血栓切除系统。Artix 专为外周动脉系统的独特需求而设计，是一种结合了吸引和机械血栓切除的解决方案，提供了程序控制和灵活性，旨在为动脉血栓切除设定新的标准。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Artix™ Thrombectomy System</p>
<div class="lb-trans"><p>Artix™血栓切除系统</p>
</div><p>An arterial blood clot in the leg is a life- and limb-threatening emergency requiring immediate treatment. However, existing therapies for arterial thromboembolism can lead to:</p>
<div class="lb-trans"><p>腿部的动脉血栓是一种危及生命和肢体的紧急情况，需要立即治疗。然而，现有的动脉血栓栓塞治疗可能导致：</p>
</div><ul>
<li>Ineffective clot retrieval leading to additional procedures (open surgery or amputation1,2)</li>
<li>Significant blood loss1</li>
<li>Adverse events such as arterial embolization and vessel trauma2,3</li>
<li>High rates of lytic use, which may result in complications1,2</li>
</ul>
<div class="lb-trans"><ul>
<li>无效的血栓取出，导致额外的手术（开放手术或截肢 1,2）</li>
<li>大量失血 1</li>
<li>不良事件，如动脉栓塞和血管损伤 2,3</li>
<li>溶栓药物使用率高，可能导致并发症 1,2</li>
</ul>
</div><p>The Artix System builds on the success of Inari's venous thrombectomy devices and is its inaugural entry into the arterial space. Inari offers a comprehensive toolkit approach to arterial thrombectomy with an innovative, over-the-wire system that provides physicians with the flexibility to aspirate and/or mechanically extract a clot.</p>
<div class="lb-trans"><p>Artix 系统建立在 Inari 静脉血栓切除设备成功的基础上，是其首次进入动脉领域。Inari 提供了一种全面的工具包方法来进行动脉血栓切除，采用创新的导线系统，使医生能够灵活地吸引和/或机械性提取血栓。</p>
</div><p>Jonathan Bowman, MD FACS, Chief of Vascular at Norwalk Hospital in Norwalk, CT, performed the first commercial case with Artix on October 19, 2024. &#34;The Artix Thrombectomy System marks a significant advancement in peripheral arterial thromboembolism treatment,&#34; said Dr. Bowman. &#34;With Artix, I finally have a solution that effectively addresses a wide range of clots while enabling me to maintain vessel access and retain control throughout the entire case. I expect Artix will take the place of open surgical repair in many of my arterial cases.&#34;</p>
<div class="lb-trans"><p>康涅狄格州诺沃克医院血管外科主任 Jonathan Bowman 博士于 2024 年 10 月 19 日进行了首例 Artix 商业案例。Bowman 博士表示：“Artix 血栓切除系统标志着外周动脉血栓栓塞治疗的重大进展。使用 Artix，我终于有了一个有效解决各种血栓的方案，同时能够在整个过程中保持血管通路和控制。我预计 Artix 将在我的许多动脉病例中取代开放手术修复。”</p>
</div><p>Key distinctive features of the Artix system include:</p>
<div class="lb-trans"><p>Artix 系统的主要独特特点包括：</p>
</div><ul>
<li><strong>Dual mechanical thrombectomy and aspiration toolkit</strong> designed to remove acute to chronic clots in a single session via a streamlined procedure4</li>
<li><strong>Aspiration-capable, 8 Fr. low profile, trackable, kink-resistant sheath in both 65cm and 90cm lengths</strong> expands treatment options by enabling more complex and distal interventions</li>
<li><strong>Innovative over-the-wire mechanical element</strong> designed to effectively collect and retrieve acute-to-chronic clot4</li>
<li><strong>Covered nitinol mesh funnel</strong> provides temporary flow restriction during the procedure to minimize the risk of arterial clot migration5</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>双重机械血栓切除和吸引工具包</strong>，旨在通过简化的程序在一次会话中去除急性到慢性血栓 4</li>
<li><strong>具备吸引功能的 8 Fr 低剖面、可追踪、抗弯曲的鞘管，长度为 65cm 和 90cm</strong>，通过支持更复杂和远端的干预扩展治疗选项</li>
<li><strong>创新的导线机械元件</strong>，旨在有效收集和提取急性至慢性血栓 4</li>
<li><strong>覆盖的镍钛合金网漏斗</strong>，在手术过程中提供临时流量限制，以最小化动脉血栓迁移的风险 5</li>
</ul>
</div><p>&#34;There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy,&#34; said Tom Tu, MD, Chief Medical Officer of Inari Medical. &#34;We are excited to bring Inari's core competency in thrombectomy to the arterial space with the goal of improving outcomes.&#34;</p>
<div class="lb-trans"><p>“确实需要解决慢性血栓并降低血栓迁移的风险。Artix 将提升有效动脉血栓切除的标准，” Inari Medical 首席医疗官 Tom Tu 博士表示。“我们很高兴将 Inari 在血栓切除方面的核心能力带入动脉领域，以改善治疗结果。”</p>
</div><p><strong>For more information, visit https://www.inarimedical.com/artix-system</strong></p>
<div class="lb-trans"><p><strong>欲了解更多信息，请访问 https://www.inarimedical.com/artix-system</strong></p>
</div><p><strong>About Stryker</strong> Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.</p>
<div class="lb-trans"><p><strong>关于 Stryker</strong> Stryker 是全球医疗技术的领导者，与我们的客户一起，我们致力于改善医疗保健。我们提供创新的产品和服务，涵盖外科、神经技术和骨科，帮助改善患者和医疗保健结果。与全球客户一起，我们每年影响超过 1.5 亿名患者。更多信息请访问 www.stryker.com。</p>
</div><p>On February 19, 2025, Stryker acquired Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.</p>
<div class="lb-trans"><p>2025 年 2 月 19 日，Stryker 收购了 Inari Medical，这是一家致力于治疗和改善患有静脉及其他疾病的患者生活的医疗设备公司。</p>
</div><p><strong>Media contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系人：</strong></p>
</div><p>Sherri Oakson</p>
<div class="lb-trans"><p>Sherri Oakson</p>
</div><p>Senior Director, Communications</p>
<div class="lb-trans"><p>高级传播总监</p>
</div><p>MedSurg and Neurotechnology</p>
<div class="lb-trans"><p>外科和神经技术</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><ol>
<li>De Donato et al. The INDIAN Trial. Eur J Vasc Endovasc Surg. 2021; 61: 820-828.</li>
<li>Heller et al. Percutaneous Mechanical Thrombectomy Using Rotarex Device in Acute Limb Ischemia in Infrainguinal Occlusions. BioMed Research International. 2017.</li>
<li>Olinic et al. Acute Limb Ischemia: An Update on Diagnosis and Management. J Clin Med. 2019.</li>
<li>Designed to remove acute to chronic arterial clots. According to benchtop testing compared to control. Internal data on file. Narula et al. JACC 2018;72:2153-63</li>
<li>According to benchtop testing compared to control. Internal data on file. NOTE: To attempt to minimize risk of arterial embolization of blood clots, use of a device that entraps clots may potentially be helpful, but this has not yet been demonstrated to be effective in the arterial system.</li>
</ol>
<div class="lb-trans"><ol>
<li>De Donato 等。INDIAN 试验。Eur J Vasc Endovasc Surg. 2021; 61: 820-828。</li>
<li>Heller 等。使用 Rotarex 设备进行急性肢体缺血的经皮机械血栓切除。BioMed Research International. 2017。</li>
<li>Olinic 等。急性肢体缺血：诊断和管理的更新。J Clin Med. 2019。</li>
<li>旨在去除急性到慢性动脉血栓。根据与对照组的台式测试。内部数据存档。Narula 等。JACC 2018;72:2153-63</li>
<li>根据与对照组的台式测试。内部数据存档。注意：为了尽量减少动脉血栓迁移的风险，使用一种能够捕捉血栓的设备可能会有帮助，但这尚未在动脉系统中证明有效。</li>
</ol>
</div><p>Dr. Jonathan Bowman is a paid consultant of Inari Medical. All views and opinions expressed here by Dr. Jonathan Bowman are his own and do not represent those of Inari Medical.</p>
<div class="lb-trans"><p>Jonathan Bowman 博士是 Inari Medical 的有偿顾问。Jonathan Bowman 博士在此表达的所有观点和意见均为他个人的观点，并不代表 Inari Medical 的观点。</p>
</div><p><strong>Indications for Use:</strong> The Artix thin-walled sheath is indicated for: (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. (3) Use as a conduit for endovascular devices. (4) Use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel. The funnel provides temporary vascular occlusion during these and other angiographic procedures. The Artix thin-walled sheath is intended for use in the peripheral vasculature. The Artix MT thrombectomy device is indicated for (1) the non-surgical removal of emboli and thrombi from a blood vessel; and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Artix MT thrombectomy device is intended for use in the peripheral vasculature. The Artix AX aspiration catheter is indicated for (1) the non-surgical removal of emboli and thrombi from blood vessels; and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Artix AX aspiration catheter is intended for use in the peripheral vasculature. The FlowSaver blood return system is used with Inari Medical catheters and sheaths for autologous blood transfusion.</p>
<div class="lb-trans"><p><strong>使用指征：</strong> Artix 薄壁鞘管适用于：（1）非手术去除血管中的栓子和血栓。（2）将对比剂和其他液体注入、输注和/或从血管中吸引。（3）作为血管内设备的导管。（4）用于促进将血管内导管插入并引导至选定血管。该漏斗在这些和其他血管造影程序中提供临时血管阻塞。Artix 薄壁鞘管旨在用于外周血管。Artix MT 血栓切除设备适用于（1）非手术去除血管中的栓子和血栓；（2）将对比剂和其他液体注入、输注和/或从血管中吸引。Artix MT 血栓切除设备旨在用于外周血管。Artix AX 吸引导管适用于（1）非手术去除血管中的栓子和血栓；（2）将对比剂和其他液体注入、输注和/或从血管中吸引。Artix AX 吸引导管旨在用于外周血管。FlowSaver 血液回流系统与 Inari Medical 导管和鞘管一起用于自体血液输血。</p>
</div><p>Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of these products.</p>
<div class="lb-trans"><p>在使用这些产品之前，请仔细阅读使用说明、适应症、警告、注意事项、可能的不良反应和禁忌症。</p>
</div><p>SOURCE Stryker</p>
<div class="lb-trans"><p>来源：Stryker</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DE35463&amp;Transmission_Id=202503061336PR_NEWS_USPR_____DE35463&amp;DateId=20250306"/></p>

13:36 ET
			
			
				Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

Inari Medical，现在是 Stryker 的一部分，推出了 Artix™ Thrombectomy System，旨在解决广泛的动脉血栓病例